课题基金 / 基金详情

A binational study to understand dementia risk and disparity among Mexican Americans: The role of Migration and Social Determinants

A binational study to understand dementia risk and disparity among Mexican Americans: The role of Migration and Social Determinants
一项旨在了解墨西哥裔美国人痴呆症风险和差异的两国研究:移民和社会决定因素的作用
批准号:
9968663
负责人:
Medellena Maria Glymour
金额:
$135.1万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-15 至 2022-08-31

项目摘要

项目成果

Medellena Maria Glymour的其他基金

相似基金

相关文献

中文摘要
翻译
摘要-来自原始应用程序-没有更改 墨西哥裔美国人是美国人中的大多数,人们对他们的痴呆症差异知之甚少。 州(美国)拉丁裔。与墨西哥裔美国人相比,墨西哥裔美国人面临着巨大的社会劣势 美国的非拉丁裔白人,包括较低的教育,较低的社会经济地位和移民- 相关的压力源。 尽管持续处于劣势,但有限的可用证据表明,墨西哥裔美国人 痴呆症的发病率与非拉丁裔白人相似。墨西哥裔美国人意想不到的健康优势 还观察到了许多其他健康后果。选择性迁徙,都是健康的人 从墨西哥到美国,不健康的成年人返回墨西哥,是一个主要的解释 墨西哥裔美国人的健康优势。几个已知的痴呆症危险因素也是预测因素 从墨西哥到美国的移民数量。然而,还没有工作对选择性迁徙及其偏见进行量化 介绍墨西哥裔美国人和非拉丁裔白人在痴呆症方面的比较 风险。因此,尚不清楚墨西哥裔美国人是否存在痴呆症风险差异 修正选择性迁徙。在这项研究中,我们建议将来自两个协调的、 50岁以上成年人的全国代表性队列:美国健康和退休研究(HRS, N=26,690人,包括2,452名墨西哥裔美国人)和墨西哥健康和老龄化研究(MHAS, N=13,798)。这些队列包括协调的纵向认知测量,这些测量与 痴呆症风险。利用仅限于美国的数据,几乎不可能将选择性移民计算在内。组合数据 来自墨西哥和美国的队列,我们包括移民和非移民,允许我们测试 墨西哥人在痴呆症风险和导致痴呆症风险的主要因素方面是否存在差异 美国人在考虑到移民模式后。这项两国研究将使我们能够(目标1)量化 有选择地从墨西哥移民到美国,并将移民返回墨西哥作为既定的功能 可能影响迁移模式的儿童和成人痴呆症危险因素。然后,我们将创建一个 “迁徙倾向”得分。这个分数将采用一种新的方法来评估社会责任的贡献 基于对墨西哥裔美国人相对社会地位的评估,导致选择性移民偏见的因素 出生在墨西哥,在美国出生的墨西哥裔美国人,以及在美国出生的非拉丁裔白人,而不是直接 比较绝对社会地位相同的人。用这个分数来解释选择偏向, 我们将展示墨西哥裔美国人与美国人在痴呆症风险方面的(目标2)差异的大小 比较了非拉丁裔白人和(目标3)与移民到美国相关的痴呆症风险差异 给留在墨西哥的人。墨西哥社会经济因素与健康之间的联系 美国人不确定,所以我们将(目标4)确定教育、家庭和社区的影响 墨西哥裔美国人在痴呆症风险上的劣势和歧视,占选择性 迁移。这项研究将提供有关不断增长的美国人口中痴呆症风险的关键信息 以及其他弱势群体或移民群体。
英文摘要
Summary- from original application-no change Little is known about dementia disparities for Mexican Americans, who comprise the majority of United States (US) Latinos. Mexican Americans experience substantial social disadvantages compared with non-Latino whites in the US, including lower education, lower socioeconomic status, and migration- related stressors. Despite sustained disadvantage, the limited available evidence suggests that Mexican Americans exhibit similar rates of dementia as non-Latino whites. Unexpected health advantages of Mexican Americans have also been observed for many other health outcomes. Selective migration, both of healthy people from Mexico to the US and return migration of unhealthy adults back to Mexico, is a leading explanation for the Mexican American health advantage. Several known risk factors for dementia are also predictors of migration from Mexico to the US. However, no work has quantified selective migration and the bias it introduces to the comparison between Mexican American and non-Latino whites with respect to dementia risk. Therefore, it is unknown whether a dementia risk disparity exists for Mexican Americans after correcting for selective migration. In this study, we propose to combine data from two harmonized, nationally representative cohorts of adults aged 50+: the US Health and Retirement Study (HRS, n=26,690, including 2,452 Mexican Americans) and the Mexican Health and Aging Study (MHAS, n=13,798). These cohorts include harmonized longitudinal cognitive measures that are robustly linked to dementia risk. Accounting for selective migration is almost impossible with US-only data. Combining data from a Mexico- and a US- based cohort, we include both migrants and non-migrants, allowing us to test whether there are disparities in dementia risk and major factors driving dementia risk in Mexican Americans after accounting for migration patterns. This binational study will allow us to (Aim 1) quantify selective migration from Mexico to the US and return migration to Mexico as a function of established childhood and adult dementia risk factors that may influence migration patterns. We will then create a "propensity to migrate" score. This score will adopt a new approach to evaluating the contribution of social factors to selective migration bias, based on evaluating relative social position within Mexican Americans born in Mexico, US-born Mexican Americans, and US-born non-Latino whites, rather than directly comparing people with the same absolute social position. Using this score to account for selection bias, we will show the magnitude of (Aim 2) differences in dementia risk comparing Mexican Americans to US non-Latino whites and (Aim 3) differences in dementia risk associated with migration to the US, compared to people who remained in Mexico. The link between socioeconomic factors and health in Mexican Americans is uncertain, so we will (Aim 4) identify effects of education, household and neighborhood disadvantage, and discrimination on dementia risk of Mexican Americans, accounting for selective migration. This study will provide critical information about dementia risk in this growing US population and other disadvantaged or immigrant groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Building an unbiased pooled cohort for the study of lifecourse social and vascular determinants of Alzheimer's Disease and Related Disorders
  • 批准号:
    10426258
  • 项目类别:
  • 资助金额:
    $78.56万
  • 财政年份:
    2021
  • 负责人:
    Medellena Maria Glymour
  • 依托单位:
Building an unbiased pooled cohort for the study of lifecourse social and vascular determinants of Alzheimer's Disease and Related Disorders
  • 批准号:
    10222823
  • 项目类别:
  • 资助金额:
    $81.44万
  • 财政年份:
    2021
  • 负责人:
    Medellena Maria Glymour
  • 依托单位:
Building an unbiased pooled cohort for the study of lifecourse social and vascular determinants of Alzheimer's Disease and Related Disorders
  • 批准号:
    10608210
  • 项目类别:
  • 资助金额:
    $77.74万
  • 财政年份:
    2021
  • 负责人:
    Medellena Maria Glymour
  • 依托单位:
Statin Treatment and Incident Alzheimer's Disease and Related Dementias in a Large, Multi-ethnic Health Plan
国内基金
海外基金
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
  • 批准号:
    82371102
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏蕴
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位: